Analyst Ratings for CVS Health Corp. (CVS)

Updated: 2017-07-28

Analysts covering CVS Health Corp. (NYSE:CVS) have given it a consensus rating of Overweight. CVS had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 16 analysts, 1 gave an overweight rating, 8 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Investment analysts gave a few price targets for CVS. The most optimistic price target was 109, which equates to a potential upside of 38.11 percent. The most pessimistic price target was 77, which equates to a potential downside of -2.43 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -0.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.17 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 3 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

CVS has an estimated earnings growth rate of 23.24 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, though it could be better to see where the ratio stands relative to peers in the industry. CVS has a PEG ratio of 0.71.

In the last 52-weeks, CVS has achieved a high of 98.66 and a low of 69.30. Currently the stock is 13.88 percent higher than its low, and 20.01 percent lower than its 52-week high. CVS has a price/earnings ratio of 16.44. Investors typically compare the P/E ratio to a company's peers in the industry. The CVS value stock report compares CVS to some of its peers using value stock charts. The stock has a market capitalization of $79.76 billion. CVS's next earnings release will be on 0000-00-00, which is days away.